Gene · 21
Papers1,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 1,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive Evaluation of Multiple Approaches Targeting ABCB1 to Resensitize Docetaxel-Resistant Prostate Cancer Cell Lines. | Int J Mol Sci | 2022 | 36614114 | PubTator, text mining | PubMed |
| The Role of Pulmonary Surfactant Phospholipids in Fibrotic Lung Diseases. | Int J Mol Sci | 2022 | 36613771 | PubTator, text mining | PubMed |
| A case report of inherited surfactant protein deficiency: unknown cause of diffuse infiltrative diseases in Tunisia. | Tunis Med | 2022 | 36571734 | PubTator, text mining | PubMed |
| Case report: Rescue treatment with add-on selexipag in a preterm infant with suprasystemic pulmonary hypertension, pulmonary capillary hemangiomatosis, and isolated pulmonary vein stenosis. | Front Cardiovasc Med | 2022 | 36568561 | PubTator, text mining | PubMed |
| Organoid technology and applications in lung diseases: Models, mechanism research and therapy opportunities. | Front Bioeng Biotechnol | 2022 | 36568297 | PubTator, text mining | PubMed |
| Association between Genotype, Presentation, and Outcome in Childhood Idiopathic and Hereditary Pulmonary Arterial Hypertension. | J Clin Med | 2022 | 36555947 | PubTator, text mining | PubMed |
| Congenital Cystic Adenomatoid Malformation (CCAM) Type II: A Rare Case of Sudden Infant Death. | Children (Basel) | 2022 | 36553274 | PubTator, text mining | PubMed |
| The Genetic and Epigenetic Footprint in Idiopathic Pulmonary Fibrosis and Familial Pulmonary Fibrosis: A State-of-the-Art Review. | Diagnostics (Basel) | 2022 | 36553114 | PubTator, text mining | PubMed |
| Genetics in Idiopathic Pulmonary Fibrosis: A Clinical Perspective. | Diagnostics (Basel) | 2022 | 36552935 | PubTator, text mining | PubMed |
| Pathogenesis of Bronchopulmonary Dysplasia: Role of Oxidative Stress from 'Omics' Studies. | Antioxidants (Basel) | 2022 | 36552588 | PubTator, text mining | PubMed |
| Blunt Traumatic Brain Injury and Alzheimer Pathology. | Dement Geriatr Cogn Disord | 2022 | 36509085 | PubTator, text mining | PubMed |
| Revisiting the Anti-Cancer Toxicity of Clinically Approved Platinating Derivatives. | Int J Mol Sci | 2022 | 36499737 | PubTator, text mining | PubMed |
| Pantranscriptome combined with phenotypic quantification reveals germplasm kinship and regulation network of bract color variation in Bougainvillea. | Front Plant Sci | 2022 | 36466294 | PubTator, text mining | PubMed |
| Metabolic reprogramming of pulmonary fibrosis. | Front Pharmacol | 2022 | 36452229 | PubTator, text mining | PubMed |
| Dissecting exosome inhibitors: therapeutic insights into small-molecule chemicals against cancer. | Exp Mol Med | 2022 | 36446847 | PubTator, text mining | PubMed |
| Interstitial Lung Disease in Children: "Specific Conditions of Undefined Etiology" Becoming Clearer. | Children (Basel) | 2022 | 36421193 | PubTator, text mining | PubMed |
| Immune checkpoint inhibitors plus chemotherapy in patients with locally advanced or metastatic pulmonary sarcomatoid carcinoma: a multicentric real-world study. | Ther Adv Med Oncol | 2022 | 36419724 | PubTator, text mining | PubMed |
| A pyridinesulfonamide derivative FD268 suppresses cell proliferation and induces apoptosis via inhibiting PI3K pathway in acute myeloid leukemia. | PLoS One | 2022 | 36413544 | PubTator, text mining | PubMed |
| The prognostic value of tumor mutational burden related 6-gene-based Risk Score in laryngeal cancer patients. | BMC Oral Health | 2022 | 36397112 | PubTator, text mining | PubMed |
| ATP-binding cassette transporter expression is widely dysregulated in frontotemporal dementia with TDP-43 inclusions. | Front Mol Neurosci | 2022 | 36385764 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/21/papers?page=13